These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18684304)

  • 1. No association of the Val158Met COMT polymorphism with Parkinson's disease in the Greek population.
    Kalinderi K; Fidani L; Kourtesi G; Katsarou Z; Mioglou E; Bostantjopoulou S
    Eur J Neurol; 2008 Aug; 15(8):e83. PubMed ID: 18684304
    [No Abstract]   [Full Text] [Related]  

  • 2. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
    Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J
    Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
    Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
    Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-methyltransferase Val158Met polymorphism and risk of autism spectrum disorders.
    Guo T; Wang W; Liu B; Chen H; Yang C
    J Int Med Res; 2013 Jun; 41(3):725-34. PubMed ID: 23613504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population.
    Białecka M; Droździk M; Honczarenko K; Gawrońska-Szklarz B; Stankiewicz J; Dabrowska E; Kubisiak M; Kłodowska-Duda G; Opala G
    Eur Neurol; 2005; 53(2):68-73. PubMed ID: 15753616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association analysis between attention-deficit hyperactivity disorder and Val158Met polymorphism of catechol-O-methyltransferase gene].
    Zhang XN; Ruan LM; Le YP; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):322-4. PubMed ID: 12903043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population.
    Torkaman-Boutorabi A; Ali Shahidi G; Choopani S; Reza Zarrindast M
    Folia Neuropathol; 2012; 50(4):382-9. PubMed ID: 23319194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.
    Chuan L; Gao J; Lei Y; Wang R; Lu L; Zhang X
    Neurol Sci; 2015 Jan; 36(1):109-15. PubMed ID: 25060648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase (COMT) Val158Met polymorphism and risk of osteoporotic fracture.
    Cao Y; Wang D; Liu B; Yao G; Fu Y; Bi Z
    Mol Biol Rep; 2012 Mar; 39(3):2975-9. PubMed ID: 21691708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.
    Liu J; Chen P; Guo M; Lu L; Li L
    Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease.
    Xie T; Ho SL; Li LS; Ma OC
    Mov Disord; 1997 May; 12(3):426-7. PubMed ID: 9159741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
    Klebe S; Golmard JL; Nalls MA; Saad M; Singleton AB; Bras JM; Hardy J; Simon-Sanchez J; Heutink P; Kuhlenbäumer G; Charfi R; Klein C; Hagenah J; Gasser T; Wurster I; Lesage S; Lorenz D; Deuschl G; Durif F; Pollak P; Damier P; Tison F; Durr A; Amouyel P; Lambert JC; Tzourio C; Maubaret C; Charbonnier-Beaupel F; Tahiri K; Vidailhet M; Martinez M; Brice A; Corvol JC; ;
    J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):666-73. PubMed ID: 23408064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
    de Lau LM; Verbaan D; Marinus J; Heutink P; van Hilten JJ
    Mov Disord; 2012 Jan; 27(1):132-5. PubMed ID: 22083803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COMT Val158Met polymorphism as an associated risk factor for Parkinson's disease in Asian rather than Caucasian populations.
    Lechun L; Yu S; Pengling H; Changqi H
    Neurol India; 2013; 61(1):12-6. PubMed ID: 23466833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland.
    Eerola J; Launes J; Hellström O; Tienari PJ
    Neurosci Lett; 2002 Sep; 330(3):296-8. PubMed ID: 12270650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of catechol-o-methyltransferase and uterine leiomyoma.
    Ates O; Demirturk F; Toprak M; Sezer S
    Mol Cell Biochem; 2013 Mar; 375(1-2):179-83. PubMed ID: 23238870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between polymorphism of COMT gene (Val158Met) with Alzheimer's disease: An updated analysis.
    Yan W; Zhao C; Sun L; Tang B
    J Neurol Sci; 2016 Feb; 361():250-5. PubMed ID: 26810551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.
    Lee YH; Song GG
    Neurol Sci; 2014 May; 35(5):643-51. PubMed ID: 24477323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains.
    Du L; Merali Z; Poulter MO; Palkovits M; Faludi G; Anisman H
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():178-83. PubMed ID: 24389396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.